Skip to main content
. 2018 Sep 24;53(Suppl 1):19–144. doi: 10.1038/s41409-018-0318-y
N (%)
Pretransplant disease status: CR/VGPR/PR/SD/Progression 7/14/1/1/2
Donor: MRD/MURD/MMURD 19/5/1
Source of stem cell (BM/PB) 2/23
Donor age (median, range) 49 (19–77)
Donor sex (male/female) 13/12
Nº infused cells (median, range) 5.8 (2.5–8.7)
Graft - Neutrophils (yes/no) - Platelets (yes/no) 25/0 23/2
Early toxicity (≤100 days): Mucositis (1–3) / Gastrointestinal (1–3) / TMA (1–2) / CNS (neuropathy 1–2) 8/12/2/5
Acute GVHD (yes/no); chronic GVHD (yes/no) 19/6 ; 5/19